|
n (%) |
P Valuea |
| Study Cohort 1 |
Study Cohort 2 |
Control Group |
Study Cohort 1 |
Study Cohort 2 |
| Hospitalizations |
|
|
|
|
|
| Total (18-45 y) |
1552 (56.46) |
1065 (38.74) |
856 (31.14) |
<.01 |
<.01 |
| 18-19 y |
<5 |
0 (0) |
0 (0) |
— |
— |
| 20-26 y |
179 (51.88) |
133 (38.55) |
98 (28.41) |
<.01 |
<.01 |
| 27-30 y |
340 (56.86) |
245 (40.97) |
230 (38.46) |
<.01 |
<.01 |
| 31-35 y |
434 (56.81) |
348 (45.55) |
264 (34.55) |
<.01 |
<.01 |
| 36-40 y |
326 (56.50) |
186 (32.24) |
151 (26.17) |
<.01 |
<.01 |
| 41-45 y |
270 (58.57) |
153 (33.19) |
113 (24.51) |
<.01 |
<.01 |
| Outpatient visits |
|
|
|
|
|
| Total (18-45 y) |
2748 (99.96) |
2748 (99.96) |
2713 (98.69) |
<.01 |
<.01 |
| 18-19 y |
<5 |
<5 |
<5 |
— |
— |
| 20-26 y |
345 (100.00) |
345 (100.00) |
341 (98.84) |
.12 |
.04 |
| 27-30 y |
598 (100.00) |
598 (100.00) |
588 (98.33) |
<.01 |
<.01 |
| 31-35 y |
764 (100.00) |
764 (100.00) |
758 (99.21) |
.03 |
<.01 |
| 36-40 y |
577 (100.00) |
576 (99.83) |
568 (98.44) |
<.01 |
<.01 |
| 41-45 y |
460 (99.78) |
461 (100.00) |
454 (98.48) |
.07 |
<.01 |